English
简体中文
Total: £ 56.28
Published Date: 2025-04-23 | Pages: 117 | Tables: 111 | Pharma & Healthcare
The global Cancer Treatment Drugs market size was US$ 211480 million in 2024 and is forecast to a readjusted size of US$ 378570 million by 2031 with a CAGR of 8.8% during the forecast period 2025-2031.
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
Global Cancer Treatment Drugs key players include Roche, Novartis, Celgene, Bristol-Myers Squibb, etc.
North America is the largest market, with a share over 40%, followed by China, and Europe, both have a share over 30 percent.
In terms of product, Chemotherapy is the largest segment, with a share about 50%. And in terms of application, the largest application is Blood Cancer, followed by Breast Cancer, Prostate Cancer, Respiratory or Lung Cancer, etc.
The global Cancer Treatment Drugs market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
By Type: (Dominant Segment vs High-Margin Innovation)
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Roche in Europe)
- Emerging Product Trends: Chemotherapy adoption vs. Targeted Therapy premiumization
- Demand-Side Dynamics: Blood Cancer growth in China vs. Breast Cancer potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Israel
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Cancer Treatment Drugs market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Targeted Therapy in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Breast Cancer in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Chemotherapy dominance in Europe vs. Targeted Therapy demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Cancer Treatment Drugs Product Scope
1.2 Cancer Treatment Drugs by Type
1.2.1 Global Cancer Treatment Drugs Sales by Type (2020 & 2024 & 2031)
1.2.2 Chemotherapy
1.2.3 Targeted Therapy
1.2.4 Immunotherapy
1.2.5 Hormonal Therapy (Biologic Therapy)
1.2.6 Others
1.3 Cancer Treatment Drugs by Application
1.3.1 Global Cancer Treatment Drugs Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory or Lung Cancer
1.3.7 Others
1.4 Global Cancer Treatment Drugs Market Estimates and Forecasts (2020-2031)
1.4.1 Global Cancer Treatment Drugs Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Cancer Treatment Drugs Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Cancer Treatment Drugs Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Cancer Treatment Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Cancer Treatment Drugs Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Cancer Treatment Drugs Sales Market Share by Region (2020-2025)
2.2.2 Global Cancer Treatment Drugs Revenue Market Share by Region (2020-2025)
2.3 Global Cancer Treatment Drugs Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Cancer Treatment Drugs Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Cancer Treatment Drugs Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Cancer Treatment Drugs Market Size and Prospective (2020-2031)
2.4.2 Europe Cancer Treatment Drugs Market Size and Prospective (2020-2031)
2.4.3 China Cancer Treatment Drugs Market Size and Prospective (2020-2031)
2.4.4 Japan Cancer Treatment Drugs Market Size and Prospective (2020-2031)
2.4.5 Israel Cancer Treatment Drugs Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Cancer Treatment Drugs Historic Market Review by Type (2020-2025)
3.1.1 Global Cancer Treatment Drugs Sales by Type (2020-2025)
3.1.2 Global Cancer Treatment Drugs Revenue by Type (2020-2025)
3.1.3 Global Cancer Treatment Drugs Price by Type (2020-2025)
3.2 Global Cancer Treatment Drugs Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Cancer Treatment Drugs Sales Forecast by Type (2026-2031)
3.2.2 Global Cancer Treatment Drugs Revenue Forecast by Type (2026-2031)
3.2.3 Global Cancer Treatment Drugs Price Forecast by Type (2026-2031)
3.3 Different Types Cancer Treatment Drugs Representative Players
4 Global Market Size by Application
4.1 Global Cancer Treatment Drugs Historic Market Review by Application (2020-2025)
4.1.1 Global Cancer Treatment Drugs Sales by Application (2020-2025)
4.1.2 Global Cancer Treatment Drugs Revenue by Application (2020-2025)
4.1.3 Global Cancer Treatment Drugs Price by Application (2020-2025)
4.2 Global Cancer Treatment Drugs Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Cancer Treatment Drugs Sales Forecast by Application (2026-2031)
4.2.2 Global Cancer Treatment Drugs Revenue Forecast by Application (2026-2031)
4.2.3 Global Cancer Treatment Drugs Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Cancer Treatment Drugs Application
5 Competition Landscape by Players
5.1 Global Cancer Treatment Drugs Sales by Players (2020-2025)
5.2 Global Top Cancer Treatment Drugs Players by Revenue (2020-2025)
5.3 Global Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Treatment Drugs as of 2024)
5.4 Global Cancer Treatment Drugs Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Cancer Treatment Drugs, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Cancer Treatment Drugs, Product Type & Application
5.7 Global Key Manufacturers of Cancer Treatment Drugs, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Cancer Treatment Drugs Sales by Company
6.1.1.1 North America Cancer Treatment Drugs Sales by Company (2020-2025)
6.1.1.2 North America Cancer Treatment Drugs Revenue by Company (2020-2025)
6.1.2 North America Cancer Treatment Drugs Sales Breakdown by Type (2020-2025)
6.1.3 North America Cancer Treatment Drugs Sales Breakdown by Application (2020-2025)
6.1.4 North America Cancer Treatment Drugs Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Cancer Treatment Drugs Sales by Company
6.2.1.1 Europe Cancer Treatment Drugs Sales by Company (2020-2025)
6.2.1.2 Europe Cancer Treatment Drugs Revenue by Company (2020-2025)
6.2.2 Europe Cancer Treatment Drugs Sales Breakdown by Type (2020-2025)
6.2.3 Europe Cancer Treatment Drugs Sales Breakdown by Application (2020-2025)
6.2.4 Europe Cancer Treatment Drugs Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Cancer Treatment Drugs Sales by Company
6.3.1.1 China Cancer Treatment Drugs Sales by Company (2020-2025)
6.3.1.2 China Cancer Treatment Drugs Revenue by Company (2020-2025)
6.3.2 China Cancer Treatment Drugs Sales Breakdown by Type (2020-2025)
6.3.3 China Cancer Treatment Drugs Sales Breakdown by Application (2020-2025)
6.3.4 China Cancer Treatment Drugs Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Cancer Treatment Drugs Sales by Company
6.4.1.1 Japan Cancer Treatment Drugs Sales by Company (2020-2025)
6.4.1.2 Japan Cancer Treatment Drugs Revenue by Company (2020-2025)
6.4.2 Japan Cancer Treatment Drugs Sales Breakdown by Type (2020-2025)
6.4.3 Japan Cancer Treatment Drugs Sales Breakdown by Application (2020-2025)
6.4.4 Japan Cancer Treatment Drugs Major Customer
6.4.5 Japan Market Trend and Opportunities
6.5 Israel Market: Players, Segments, Downstream and Major Customers
6.5.1 Israel Cancer Treatment Drugs Sales by Company
6.5.1.1 Israel Cancer Treatment Drugs Sales by Company (2020-2025)
6.5.1.2 Israel Cancer Treatment Drugs Revenue by Company (2020-2025)
6.5.2 Israel Cancer Treatment Drugs Sales Breakdown by Type (2020-2025)
6.5.3 Israel Cancer Treatment Drugs Sales Breakdown by Application (2020-2025)
6.5.4 Israel Cancer Treatment Drugs Major Customer
6.5.5 Israel Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Roche
7.1.1 Roche Company Information
7.1.2 Roche Business Overview
7.1.3 Roche Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Roche Cancer Treatment Drugs Products Offered
7.1.5 Roche Recent Development
7.2 Novartis
7.2.1 Novartis Company Information
7.2.2 Novartis Business Overview
7.2.3 Novartis Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Novartis Cancer Treatment Drugs Products Offered
7.2.5 Novartis Recent Development
7.3 Celgene
7.3.1 Celgene Company Information
7.3.2 Celgene Business Overview
7.3.3 Celgene Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Celgene Cancer Treatment Drugs Products Offered
7.3.5 Celgene Recent Development
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Information
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Bristol-Myers Squibb Cancer Treatment Drugs Products Offered
7.4.5 Bristol-Myers Squibb Recent Development
7.5 Amgen
7.5.1 Amgen Company Information
7.5.2 Amgen Business Overview
7.5.3 Amgen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Amgen Cancer Treatment Drugs Products Offered
7.5.5 Amgen Recent Development
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Information
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Johnson & Johnson Cancer Treatment Drugs Products Offered
7.6.5 Johnson & Johnson Recent Development
7.7 Pfizer
7.7.1 Pfizer Company Information
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Pfizer Cancer Treatment Drugs Products Offered
7.7.5 Pfizer Recent Development
7.8 Takeda
7.8.1 Takeda Company Information
7.8.2 Takeda Business Overview
7.8.3 Takeda Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Takeda Cancer Treatment Drugs Products Offered
7.8.5 Takeda Recent Development
7.9 Eli Lilly
7.9.1 Eli Lilly Company Information
7.9.2 Eli Lilly Business Overview
7.9.3 Eli Lilly Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Eli Lilly Cancer Treatment Drugs Products Offered
7.9.5 Eli Lilly Recent Development
7.10 AstraZeneca
7.10.1 AstraZeneca Company Information
7.10.2 AstraZeneca Business Overview
7.10.3 AstraZeneca Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.10.4 AstraZeneca Cancer Treatment Drugs Products Offered
7.10.5 AstraZeneca Recent Development
7.11 Astellas
7.11.1 Astellas Company Information
7.11.2 Astellas Business Overview
7.11.3 Astellas Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Astellas Cancer Treatment Drugs Products Offered
7.11.5 Astellas Recent Development
7.12 Merck & Co.
7.12.1 Merck & Co. Company Information
7.12.2 Merck & Co. Business Overview
7.12.3 Merck & Co. Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Merck & Co. Cancer Treatment Drugs Products Offered
7.12.5 Merck & Co. Recent Development
7.13 Sanofi
7.13.1 Sanofi Company Information
7.13.2 Sanofi Business Overview
7.13.3 Sanofi Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Sanofi Cancer Treatment Drugs Products Offered
7.13.5 Sanofi Recent Development
7.14 Bayer
7.14.1 Bayer Company Information
7.14.2 Bayer Business Overview
7.14.3 Bayer Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Bayer Cancer Treatment Drugs Products Offered
7.14.5 Bayer Recent Development
7.15 Biogen Idec
7.15.1 Biogen Idec Company Information
7.15.2 Biogen Idec Business Overview
7.15.3 Biogen Idec Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Biogen Idec Cancer Treatment Drugs Products Offered
7.15.5 Biogen Idec Recent Development
7.16 Eisai
7.16.1 Eisai Company Information
7.16.2 Eisai Business Overview
7.16.3 Eisai Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Eisai Cancer Treatment Drugs Products Offered
7.16.5 Eisai Recent Development
7.17 Teva
7.17.1 Teva Company Information
7.17.2 Teva Business Overview
7.17.3 Teva Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.17.4 Teva Cancer Treatment Drugs Products Offered
7.17.5 Teva Recent Development
7.18 Otsuka
7.18.1 Otsuka Company Information
7.18.2 Otsuka Business Overview
7.18.3 Otsuka Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.18.4 Otsuka Cancer Treatment Drugs Products Offered
7.18.5 Otsuka Recent Development
7.19 Merck KGaA
7.19.1 Merck KGaA Company Information
7.19.2 Merck KGaA Business Overview
7.19.3 Merck KGaA Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.19.4 Merck KGaA Cancer Treatment Drugs Products Offered
7.19.5 Merck KGaA Recent Development
7.20 Ipsen
7.20.1 Ipsen Company Information
7.20.2 Ipsen Business Overview
7.20.3 Ipsen Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.20.4 Ipsen Cancer Treatment Drugs Products Offered
7.20.5 Ipsen Recent Development
7.21 AbbVie
7.21.1 AbbVie Company Information
7.21.2 AbbVie Business Overview
7.21.3 AbbVie Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.21.4 AbbVie Cancer Treatment Drugs Products Offered
7.21.5 AbbVie Recent Development
7.22 Gilead Sciences
7.22.1 Gilead Sciences Company Information
7.22.2 Gilead Sciences Business Overview
7.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Revenue and Gross Margin (2020-2025)
7.22.4 Gilead Sciences Cancer Treatment Drugs Products Offered
7.22.5 Gilead Sciences Recent Development
8 Cancer Treatment Drugs Manufacturing Cost Analysis
8.1 Cancer Treatment Drugs Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Cancer Treatment Drugs
8.4 Cancer Treatment Drugs Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Cancer Treatment Drugs Distributors List
9.3 Cancer Treatment Drugs Customers
10 Cancer Treatment Drugs Market Dynamics
10.1 Cancer Treatment Drugs Industry Trends
10.2 Cancer Treatment Drugs Market Drivers
10.3 Cancer Treatment Drugs Market Challenges
10.4 Cancer Treatment Drugs Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Cancer Treatment Drugs Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Cancer Treatment Drugs Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Cancer Treatment Drugs Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Cancer Treatment Drugs Sales (K Pcs) by Region (2020-2025)
Table 5. Global Cancer Treatment Drugs Sales Market Share by Region (2020-2025)
Table 6. Global Cancer Treatment Drugs Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Cancer Treatment Drugs Revenue Share by Region (2020-2025)
Table 8. Global Cancer Treatment Drugs Sales (K Pcs) Forecast by Region (2026-2031)
Table 9. Global Cancer Treatment Drugs Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Cancer Treatment Drugs Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Cancer Treatment Drugs Revenue Share Forecast by Region (2026-2031)
Table 12. Global Cancer Treatment Drugs Sales by Type (K Pcs) & (2020-2025)
Table 13. Global Cancer Treatment Drugs Sales Share by Type (2020-2025)
Table 14. Global Cancer Treatment Drugs Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Cancer Treatment Drugs Price by Type (USD/Pcs) & (2020-2025)
Table 16. Global Cancer Treatment Drugs Sales by Type (K Pcs) & (2026-2031)
Table 17. Global Cancer Treatment Drugs Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Cancer Treatment Drugs Price by Type (USD/Pcs) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Cancer Treatment Drugs Sales by Application (K Pcs) & (2020-2025)
Table 21. Global Cancer Treatment Drugs Sales Share by Application (2020-2025)
Table 22. Global Cancer Treatment Drugs Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Cancer Treatment Drugs Price by Application (USD/Pcs) & (2020-2025)
Table 24. Global Cancer Treatment Drugs Sales by Application (K Pcs) & (2026-2031)
Table 25. Global Cancer Treatment Drugs Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Cancer Treatment Drugs Price by Application (USD/Pcs) & (2026-2031)
Table 27. New Sources of Growth in Cancer Treatment Drugs Application
Table 28. Global Cancer Treatment Drugs Sales by Company (K Pcs) & (2020-2025)
Table 29. Global Cancer Treatment Drugs Sales Share by Company (2020-2025)
Table 30. Global Cancer Treatment Drugs Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Cancer Treatment Drugs Revenue Share by Company (2020-2025)
Table 32. Global Cancer Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Treatment Drugs as of 2024)
Table 33. Global Market Cancer Treatment Drugs Average Price by Company (USD/Pcs) & (2020-2025)
Table 34. Global Key Manufacturers of Cancer Treatment Drugs, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Cancer Treatment Drugs, Product Type & Application
Table 36. Global Key Manufacturers of Cancer Treatment Drugs, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Cancer Treatment Drugs Sales by Company (2020-2025) & (K Pcs)
Table 39. North America Cancer Treatment Drugs Sales Market Share by Company (2020-2025)
Table 40. North America Cancer Treatment Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Cancer Treatment Drugs Revenue Market Share by Company (2020-2025)
Table 42. North America Cancer Treatment Drugs Sales by Type (2020-2025) & (K Pcs)
Table 43. North America Cancer Treatment Drugs Sales Market Share by Type (2020-2025)
Table 44. North America Cancer Treatment Drugs Sales by Application (2020-2025) & (K Pcs)
Table 45. North America Cancer Treatment Drugs Sales Market Share by Application (2020-2025)
Table 46. Europe Cancer Treatment Drugs Sales by Company (2020-2025) & (K Pcs)
Table 47. Europe Cancer Treatment Drugs Sales Market Share by Company (2020-2025)
Table 48. Europe Cancer Treatment Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Cancer Treatment Drugs Revenue Market Share by Company (2020-2025)
Table 50. Europe Cancer Treatment Drugs Sales by Type (2020-2025) & (K Pcs)
Table 51. Europe Cancer Treatment Drugs Sales Market Share by Type (2020-2025)
Table 52. Europe Cancer Treatment Drugs Sales by Application (2020-2025) & (K Pcs)
Table 53. Europe Cancer Treatment Drugs Sales Market Share by Application (2020-2025)
Table 54. China Cancer Treatment Drugs Sales by Company (2020-2025) & (K Pcs)
Table 55. China Cancer Treatment Drugs Sales Market Share by Company (2020-2025)
Table 56. China Cancer Treatment Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Cancer Treatment Drugs Revenue Market Share by Company (2020-2025)
Table 58. China Cancer Treatment Drugs Sales by Type (2020-2025) & (K Pcs)
Table 59. China Cancer Treatment Drugs Sales Market Share by Type (2020-2025)
Table 60. China Cancer Treatment Drugs Sales by Application (2020-2025) & (K Pcs)
Table 61. China Cancer Treatment Drugs Sales Market Share by Application (2020-2025)
Table 62. Japan Cancer Treatment Drugs Sales by Company (2020-2025) & (K Pcs)
Table 63. Japan Cancer Treatment Drugs Sales Market Share by Company (2020-2025)
Table 64. Japan Cancer Treatment Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Cancer Treatment Drugs Revenue Market Share by Company (2020-2025)
Table 66. Japan Cancer Treatment Drugs Sales by Type (2020-2025) & (K Pcs)
Table 67. Japan Cancer Treatment Drugs Sales Market Share by Type (2020-2025)
Table 68. Japan Cancer Treatment Drugs Sales by Application (2020-2025) & (K Pcs)
Table 69. Japan Cancer Treatment Drugs Sales Market Share by Application (2020-2025)
Table 70. Israel Cancer Treatment Drugs Sales by Company (2020-2025) & (K Pcs)
Table 71. Israel Cancer Treatment Drugs Sales Market Share by Company (2020-2025)
Table 72. Israel Cancer Treatment Drugs Revenue by Company (2020-2025) & (US$ Million)
Table 73. Israel Cancer Treatment Drugs Revenue Market Share by Company (2020-2025)
Table 74. Israel Cancer Treatment Drugs Sales by Type (2020-2025) & (K Pcs)
Table 75. Israel Cancer Treatment Drugs Sales Market Share by Type (2020-2025)
Table 76. Israel Cancer Treatment Drugs Sales by Application (2020-2025) & (K Pcs)
Table 77. Israel Cancer Treatment Drugs Sales Market Share by Application (2020-2025)
Table 78. Roche Company Information
Table 79. Roche Description and Business Overview
Table 80. Roche Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 81. Roche Cancer Treatment Drugs Product
Table 82. Roche Recent Development
Table 83. Novartis Company Information
Table 84. Novartis Description and Business Overview
Table 85. Novartis Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 86. Novartis Cancer Treatment Drugs Product
Table 87. Novartis Recent Development
Table 88. Celgene Company Information
Table 89. Celgene Description and Business Overview
Table 90. Celgene Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 91. Celgene Cancer Treatment Drugs Product
Table 92. Celgene Recent Development
Table 93. Bristol-Myers Squibb Company Information
Table 94. Bristol-Myers Squibb Description and Business Overview
Table 95. Bristol-Myers Squibb Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 96. Bristol-Myers Squibb Cancer Treatment Drugs Product
Table 97. Bristol-Myers Squibb Recent Development
Table 98. Amgen Company Information
Table 99. Amgen Description and Business Overview
Table 100. Amgen Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 101. Amgen Cancer Treatment Drugs Product
Table 102. Amgen Recent Development
Table 103. Johnson & Johnson Company Information
Table 104. Johnson & Johnson Description and Business Overview
Table 105. Johnson & Johnson Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 106. Johnson & Johnson Cancer Treatment Drugs Product
Table 107. Johnson & Johnson Recent Development
Table 108. Pfizer Company Information
Table 109. Pfizer Description and Business Overview
Table 110. Pfizer Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 111. Pfizer Cancer Treatment Drugs Product
Table 112. Pfizer Recent Development
Table 113. Takeda Company Information
Table 114. Takeda Description and Business Overview
Table 115. Takeda Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 116. Takeda Cancer Treatment Drugs Product
Table 117. Takeda Recent Development
Table 118. Eli Lilly Company Information
Table 119. Eli Lilly Description and Business Overview
Table 120. Eli Lilly Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 121. Eli Lilly Cancer Treatment Drugs Product
Table 122. Eli Lilly Recent Development
Table 123. AstraZeneca Company Information
Table 124. AstraZeneca Description and Business Overview
Table 125. AstraZeneca Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 126. AstraZeneca Cancer Treatment Drugs Product
Table 127. AstraZeneca Recent Development
Table 128. Astellas Company Information
Table 129. Astellas Description and Business Overview
Table 130. Astellas Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 131. Astellas Cancer Treatment Drugs Product
Table 132. Astellas Recent Development
Table 133. Merck & Co. Company Information
Table 134. Merck & Co. Description and Business Overview
Table 135. Merck & Co. Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 136. Merck & Co. Cancer Treatment Drugs Product
Table 137. Merck & Co. Recent Development
Table 138. Sanofi Company Information
Table 139. Sanofi Description and Business Overview
Table 140. Sanofi Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 141. Sanofi Cancer Treatment Drugs Product
Table 142. Sanofi Recent Development
Table 143. Bayer Company Information
Table 144. Bayer Description and Business Overview
Table 145. Bayer Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 146. Bayer Cancer Treatment Drugs Product
Table 147. Bayer Recent Development
Table 148. Biogen Idec Company Information
Table 149. Biogen Idec Description and Business Overview
Table 150. Biogen Idec Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 151. Biogen Idec Cancer Treatment Drugs Product
Table 152. Biogen Idec Recent Development
Table 153. Eisai Company Information
Table 154. Eisai Description and Business Overview
Table 155. Eisai Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 156. Eisai Cancer Treatment Drugs Product
Table 157. Eisai Recent Development
Table 158. Teva Company Information
Table 159. Teva Description and Business Overview
Table 160. Teva Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 161. Teva Cancer Treatment Drugs Product
Table 162. Teva Recent Development
Table 163. Otsuka Company Information
Table 164. Otsuka Description and Business Overview
Table 165. Otsuka Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 166. Otsuka Cancer Treatment Drugs Product
Table 167. Otsuka Recent Development
Table 168. Merck KGaA Company Information
Table 169. Merck KGaA Description and Business Overview
Table 170. Merck KGaA Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 171. Merck KGaA Cancer Treatment Drugs Product
Table 172. Merck KGaA Recent Development
Table 173. Ipsen Company Information
Table 174. Ipsen Description and Business Overview
Table 175. Ipsen Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 176. Ipsen Cancer Treatment Drugs Product
Table 177. Ipsen Recent Development
Table 178. AbbVie Company Information
Table 179. AbbVie Description and Business Overview
Table 180. AbbVie Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 181. AbbVie Cancer Treatment Drugs Product
Table 182. AbbVie Recent Development
Table 183. Gilead Sciences Company Information
Table 184. Gilead Sciences Description and Business Overview
Table 185. Gilead Sciences Cancer Treatment Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 186. Gilead Sciences Cancer Treatment Drugs Product
Table 187. Gilead Sciences Recent Development
Table 188. Production Base and Market Concentration Rate of Raw Material
Table 189. Key Suppliers of Raw Materials
Table 190. Cancer Treatment Drugs Distributors List
Table 191. Cancer Treatment Drugs Customers List
Table 192. Cancer Treatment Drugs Market Trends
Table 193. Cancer Treatment Drugs Market Drivers
Table 194. Cancer Treatment Drugs Market Challenges
Table 195. Cancer Treatment Drugs Market Restraints
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Cancer Treatment Drugs Product Picture
Figure 2. Global Cancer Treatment Drugs Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Cancer Treatment Drugs Sales Market Share by Type in 2024 & 2031
Figure 4. Chemotherapy Product Picture
Figure 5. Targeted Therapy Product Picture
Figure 6. Immunotherapy Product Picture
Figure 7. Hormonal Therapy (Biologic Therapy) Product Picture
Figure 8. Others Product Picture
Figure 9. Global Cancer Treatment Drugs Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 10. Global Cancer Treatment Drugs Sales Market Share by Application in 2024 & 2031
Figure 11. Blood Cancer Examples
Figure 12. Breast Cancer Examples
Figure 13. Gastrointestinal Cancer Examples
Figure 14. Prostate Cancer Examples
Figure 15. Respiratory or Lung Cancer Examples
Figure 16. Others Examples
Figure 17. Global Cancer Treatment Drugs Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Cancer Treatment Drugs Sales Growth Rate (2020-2031) & (US$ Million)
Figure 19. Global Cancer Treatment Drugs Sales (K Pcs) Growth Rate (2020-2031)
Figure 20. Global Cancer Treatment Drugs Price Trends Growth Rate (2020-2031) & (USD/Pcs)
Figure 21. Cancer Treatment Drugs Report Years Considered
Figure 22. Global Market Cancer Treatment Drugs Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 23. Global Cancer Treatment Drugs Revenue Market Share by Region: 2020 VS 2024
Figure 24. North America Cancer Treatment Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. North America Cancer Treatment Drugs Sales (K Pcs) Growth Rate (2020-2031)
Figure 26. Europe Cancer Treatment Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 27. Europe Cancer Treatment Drugs Sales (K Pcs) Growth Rate (2020-2031)
Figure 28. China Cancer Treatment Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 29. China Cancer Treatment Drugs Sales (K Pcs) Growth Rate (2020-2031)
Figure 30. Japan Cancer Treatment Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 31. Japan Cancer Treatment Drugs Sales (K Pcs) Growth Rate (2020-2031)
Figure 32. Israel Cancer Treatment Drugs Revenue (US$ Million) Growth Rate (2020-2031)
Figure 33. Israel Cancer Treatment Drugs Sales (K Pcs) Growth Rate (2020-2031)
Figure 34. Global Cancer Treatment Drugs Revenue Share by Type (2020-2025)
Figure 35. Global Cancer Treatment Drugs Sales Share by Type (2026-2031)
Figure 36. Global Cancer Treatment Drugs Revenue Share by Type (2026-2031)
Figure 37. Global Cancer Treatment Drugs Revenue Share by Application (2020-2025)
Figure 38. Global Cancer Treatment Drugs Revenue Growth Rate by Application in 2020 & 2024
Figure 39. Global Cancer Treatment Drugs Sales Share by Application (2026-2031)
Figure 40. Global Cancer Treatment Drugs Revenue Share by Application (2026-2031)
Figure 41. Global Cancer Treatment Drugs Sales Share by Company (2024)
Figure 42. Global Cancer Treatment Drugs Revenue Share by Company (2024)
Figure 43. Global 5 Largest Cancer Treatment Drugs Players Market Share by Revenue in Cancer Treatment Drugs: 2020 & 2024
Figure 44. Cancer Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 45. Manufacturing Cost Structure of Cancer Treatment Drugs
Figure 46. Manufacturing Process Analysis of Cancer Treatment Drugs
Figure 47. Cancer Treatment Drugs Industrial Chain
Figure 48. Channels of Distribution (Direct Vs Distribution)
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
